Skip Navigation

  • Weekly Notice of JHU Limited Submission Opportunities 

    Along with limited submissions updates, the Office of the Vice Provost for Research (VPR) is also maintaining the JHU COVID-19 Response websiteSee the most recent updates listed below and contact us if you have any questions.

    You can also access all current COVID-19 funding opportunities here.

    Newly Added COVID-19 Opportunities

    SponsorProgramFundingDeadline
    National Institutes of Health (NIH)Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2No limitOnce a month on the 14th through 9/14/2021
    American Lung AssociationCOVID-19 and Emerging Respiratory Viruses Research Award$200,0009/23/2021
    National Institutes of Health (NIH)Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)$2,500,000 (direct costs)11/8/2021
    National Institutes of Health (NIH)Notice of Special Interest: Administrative Supplements for COVID19 Impacted NIMH ResearcVaries6/1/2023

     

     

     

     

     

     

     

     

     

    New Opportunities for August 9, 2021

    SponsorProgramLimitMaximum Award AmountInternal Application Deadline
    National Science Foundation (NSF)NSF INCLUDES Alliances: Inclusion across the Nation of Communities of Learners of Underrepresented Discoverers in Engineering and Science1$10,000,0008/24/2021
    National Science Foundation (NSF)Competition for the Management of Operations and Maintenance of the National Ecological Observatory Network (NEON)1$345,000,0008/31/2021

     

     

     

     

     

     

     

    Open Opportunities

    SponsorProgramLimitMaximum Award AmountInternal Application Deadline
    Health Resources and Services Administration (HRSA)Teaching Health Center Planning and Development – Technical Assistance1$5,000,0008/10/2021
    Health Resources and Services Administration (HRSA)Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program1$1,557,1798/10/2021
    Health Resources and Services Administration (HRSA)Health and Public Safety Workforce Resiliency Training Program1$2,280,6668/12/2021
    Health Resources and Services Administration (HRSA)Health and Public Safety Workforce Resiliency Technical Assistance Center (HPSWRTAC)1$6,000,0008/12/2021
    Environmental Protection Agency (EPA)Children’s Healthy Learning Environments in Low-Income and/or Minority Communities1$200,0008/17/2021
    Alfred P. Sloan FoundationSloan Research Fellows3 per department$75,0008/17/2021
    Howard Hughes Medical InstituteGilliam Fellowships for Advanced Study5$138,0008/24/2021
    National Science Foundation (NSF)2024 American National Election Study Competition (ANES)1$14,000,0008/17/2021
    The Greenwall FoundationGreenwall Faculty Scholars Program150% salary for 3 years, 10% IDC, $5,000/year travel and project support8/19/2021
    National Institutes of Health (NIH)Bridges to the Doctorate Research Training Program (T32)1No limit8/17/2021
    National Institutes of Health (NIH)Collaborative Program Grant for Multidisciplinary Teams (RM1 Clinical Trial Optional)1$8,750,000 (direct costs)9/7/2021
    American Roentgen Ray Society (ARRS)

    Scholarship

    Early Career Faculty

    1 per department (SOM)$180,0008/17/2021
    Apple Machine Learning ResearchApple Scholars in AI/ML PhD Fellowship3Tuition & fees, $90,000 for living & travel expenses9/2/2021
    Kleberg FoundationMedical Research Program1$1,000,0008/13/2021
    GooglePhD Fellowship Program4 (computer science or related field)Full tuition & fees + stipend for living expenses, travel & personal equipment8/17/2021
    Association for Computing Machinery (ACM)Doctoral Dissertation Competition2$20,0008/24/2021

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Limited Submissions are funding opportunities in which federal and private sponsors limit the number of proposals from an institution.  An internal competition is held in order to select the most competitive proposal(s) on behalf of the University.

    Applications are due by 11:59pm on the internal application deadline specified.  For more information, please contact us at resapp@jhu.edu.

    To see the most updated information on all current limited submission opportunities, please visit our website.

    PLEASE NOTE: A Coeus record should NOT be created for an internal application to a limited submission opportunity until selected as a JHU nominee.

  • Weekly NIH Funding Opportunities and Notices

    Policy Notices

    Notice of Changes to Funding Opportunities

    Notices of Intent to Publish

    Funding Opportunities

    Click here for NIH publication of notices of grant policies, guidelines and funding opportunity announcements (FOAs).

    Click here to view the Changes to the Biographical Sketch and Other Support Format Page for Due Dates on or after May 25, 2021. 

  • Monthly Internal Funding Opportunities

    Johns Hopkins-GlaxoSmithKline Scholars Program

    • Funding Sponsor: Center for Innovation in Graduate Biomedical Education
    • Max Amount of Award: TBD after application review with GSK
    • Due Date: Rolling until program reaches capacity
    • Notification Date: TBD
    • Description: As part of our ongoing efforts to expand PhD training program driven by academia-industry collaboration, we are soliciting proposals from Johns Hopkins investigators interested in working with investigators at GlaxoSmithKline (GSK) Vaccines (Rockville, MD) to mentor JHU graduate students pursuing a Ph.D. degree in the biomedical sciences.

      Eligibility: Johns Hopkins investigators affiliated with at least one Ph.D.-granting program at any of the schools of the Johns Hopkins University. Investigators who do not currently mentor graduate students are also encouraged to apply as long as they are eligible to mentor Ph.D. candidates.


    Small Pilot Projects

    • Funding SponsorJohns Hopkins University Older Americans Independence Center
    • Max Amount of Award: $10,000 (direct costs)
    • Due Date: Rolling basis
    • Notification Date: Rolling basis
    • Description: The Johns Hopkins Older Americans Independence Center (OAIC) solicits proposals to support of scientific projects and junior investigators in research on frailty in aging. The OAIC is a Johns Hopkins-wide Center, funded by the National Institute on Aging's Center on Aging and Health, to support the development of research on the etiology of frailty as a basis for developing treatments or approaches to prevention of frailty in older adults. Scientists with an interest in developing pilot projects in this area or with needs for support of biostatistical or genetic analyses of data related to frailty, as well as junior faculty seeking protected time to develop investigative careers in this field, are encouraged to apply for internal funding through the OAIC mechanisms. Small pilot proposals must have a hypothesis that is frailty-focused.
      Eligibility:  Anyone may apply.

    The Ignite Fund

    • Funding Sponsor: The Ignite Fund
    • Max Amount of Award: Unlimited
    • Due Date: Rolling basis
    • Notification Date: TBD
    • Description: The Ignite Fund offers Hopkins student entrepreneurs access to funding throughout the academic year. The fund’s purpose is to support discrete tasks that will help move a venture forward. In focusing funding this way, we hope to provide student ventures access to capital at key moments. Applications must identify a single discrete task to be funded. Applicant(s) must clearly demonstrate how the task to be achieved by the funding will impact their venture’s next steps. All proposals will be considered, but, in light of limited funding, successful applications will emphasize how to make the most out of minor amounts. All awards must complete their closing process (provision of final progress report and receipts) no later than May 15, 2021.
      Eligibility: All ventures with at least one current JHU student founder. Ventures who have won Ignite Fund awards previously may apply again if they have completed the closing process (provision of final progress report and receipts) prior to their newest application.

    Schaufeld Program for Prostate Cancer in Black Men

    • Funding SponsorBrady Urological Institute
    • Max Amount of Award: $100,000
    • Due Date: August 15, 2021
    • Notification Date: TBD
    • Description: The Schaufeld Program for Prostate Cancer in Black Men is an exciting new initiative from the Brady Urological Institute at Johns Hopkins which will combine scientific inquiry, education and community engagement to reduce the burden of prostate cancer on men of African ancestry. One year pilot awards of $100,000 will made available through the Schaufeld Program to support cutting-edge multidisciplinary scientific research on prostate cancer arising in Black men.  Applications examining the role of genomics, epigenomics, or microbiota/immune system/tumor interactions are particularly encouraged, as are imaging and population-science-based initiatives. Research may support the development of new and better methods for prostate cancer detection and treatment, with a specific focus on men of African ancestry.  Projects aimed at generating preliminary data for external grant funding applications will be prioritized. Funding is open to all JHU-affiliated faculty. For those without a track record of prostate cancer research, partnership with a prostate cancer-focused faculty member is highly encouraged.
      Eligibility:  All JHU-affiliated faculty.

    Developmental Research Program (Pilot Projects)

    • Funding SponsorThe Sol Goldman Pancreatic Cancer Research Center
    • Max Amount of Award: $50,000
    • Due Date: September 3, 2021
    • Notification Date: TBD
    • Description: The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins is pleased to announce that funding is available for a limited number of novel developmental research programs (pilot projects) in the study of adenocarcinoma of the pancreas. This program funds important new pilot projects with promising translational potential that do not have sufficient data for an independently funded NIH grant. Projects of high priority should focus on new research directions, explore innovative ideas, test unconventional, but potentially important, new hypotheses, or ascertain the feasibility of new research approaches. Funds ($50,000 per year with the option of re-applying for a second year of funding) may be requested for the salaries of faculty, postdoctoral fellows or technicians, for equipment, and/or for consumable supplies.
      Eligibility:  Applicants must hold an MD or PhD degree or both and must have a current academic appointment at Johns Hopkins University. Individuals with nontenure track positions should provide a letter from a tenure track faculty member describing their position and providing assurances of employment during the grant period.

    Patrick C. Walsh Prostate Cancer Research Fund

    • Funding SponsorBrady Urological Institute
    • Max Amount of Award: $200,000
    • Due Date: September 3, 2021
    • Notification Date: September 17, 2021
    • Description: Funding is available to support multidisciplinary research in prostate cancer through the Patrick C. Walsh Prostate Cancer Research Fund. For the 2021 funding cycle, pilot awards of $100,000 or multi-PI of up to $200,000 will made available to support cutting-edge multidisciplinary scientific research on prostate cancer. An emphasis will be placed on supporting work in the areas of (1) artificial intelligence / machine learning for prostate cancer, (2) the inhibition / reversal of therapeutic resistance in prostate cancer, (3) hereditary prostate cancer, and (4) novel technologies applied to prostate cancer research and care.
      Eligibility:  all JHU affiliated faculty.  Partnership with a Brady Urological Institute faculty member is highly encouraged, but not required. An investigator may hold only one pilot project award at a time. Fellows are not permitted to be principal investigators. If you are submitting an idea to the Schaufeld Program for Prostate Cancer in Black Men, please do not put in a duplicate / similar application to the PCW Fund.

    Catalyst Awards

    • Funding SponsorOffice of the Vice Provost for Research
    • Max Amount of Award: $75,000
    • Due Date: January 14, 2022
    • Notification Date: TBD
    • Description: These grant awards of up to $75,000 support the promising research and creative endeavors of our early career faculty with the goal of launching them on a path to a sustainable and rewarding academic career. We encourage applicants to propose a project that will help solidify their rising position within their field.
      Eligibility: Applications from early-career faculty in any academic or professional discipline at the university are encouraged to apply. The term “early-career” is defined as any full-time tenure-track faculty member who was first appointed to a full-time, tenure track faculty position at any institution within no less than three (3) years and no more than ten (10) years as of July 1 of the deadline year. Eligible 2022 applicants were appointed to their first full-time, tenure track faculty position between July 1, 2011 and June 30, 2019. Non-tenure-track Research Associates and Research Scientists at the School of Medicine (SOM), Bloomberg School of Public Health (BSPH), the Whiting School of Engineering (WSE), and the Krieger School of Arts and Sciences (KSAS) are NOT eligible for the Catalyst Award, but are encouraged to consider applying for the Discovery Award. Only one application per person, per year. Successful applicants will not be eligible for subsequent Catalyst Awards.

    Discovery Awards

    • Funding SponsorOffice of the Vice Provost for Research
    • Max Amount of Award: $100,000
    • Due Date: January 14, 2022
    • Notification Date: TBD
    • Description: More than ever, the answers to the most challenging questions cannot be accomplished entirely within one academic discipline, or even one division. The Johns Hopkins Discovery Awards provide grant awards to cross-divisional teams, comprised of faculty and/or non-faculty members from at least two schools or affiliates of the university, who are poised to arrive at important discoveries or creative works. The expectation is that these awards will spark new, synergistic interactions between investigators across the institution and lead to work of the highest quality and impact. These awards are not intended to support already established projects or minimal extensions of ongoing research or professional programs.

      Eligibility: Only one application per lead PI will be accepted. There is no limit to the number of proposals you can participate in as a co-PI. If you were the lead PI of a funded 2020 Discovery Award, you are not eligible to apply as the lead PI of a 2022 award. You will be eligible again in 2023. Applications from all academic and professional disciplines at the university are welcome, and may cover fundamental, applied, or clinical research in any field, as well as the development of applied creative projects in the arts and humanities. Applications must include at least two faculty members and/or APL staff members representing at least two separate schools/divisions or affiliates of the university.

  • JHU Research Response Website

    JHU Research Response Website
    JHU has developed a site with topical resources regarding JHU's COVID-19 research response

    This site serves as the primary point for communication regarding the COVID-19 event for all JHU research administration offices, including JHURA, Business and Research Administration (BARA) and the School of Medicine Office of Research Administration (ORA).

    This COVID-19 news summary will be sent weekly, but please bookmark the pages below and check back frequently, as the information is updated daily.

    NEW: COVID-19 Research Response Program

    Sponsor Guidance: Federal and Non-federal guidance: Weekly updates below.

    Federal Sponsor Guidance Non-federal Sponsor Guidance

    Research Administration FAQs: Read the NEW research administration FAQs regarding budgeting for changes in Fringe Benefits on sponsored project budgets and updated university guidance on NIH flexibilities. 

    Human Subjects: We are still in Phase 3 of the Phased Contingency Plan.

    Animal Care & Use

    COVID-19 Funding Opportunities

    COVID-19 Research Response Resources

    Personal Protective Equipment (PPE) Donation Drive 

    For the latest university updates, please visit JHU's COVID-19 Information page.    

  • Editorial Assistance Services Initiative 

    The COVID-19 pandemic has greatly affected the academic community in many ways, including in research productivity. Early career faculty, particularly women and underrepresented minorities, have been disproportionately affected (1,2,3,4,5). To provide additional support to faculty as they submit manuscripts or proposals, the university has launched the Editorial Assistance Services Initiative (EASI).

    As capacity allows, the  Research Development Team (RDT) will also assist with managing and facilitating the pre-award phase for teams who submit large grant proposal opportunities (>$5M) that support multidisciplinary and collaborative research. To request that support, please fill out the RDT Assistance Inquiry Form.

    Faculty members from all ranks and disciplines who have been affected by the COVID-19 pandemic can apply for EASI services on grant proposals and manuscripts.

    Questions? Email Courtney McQueen at cmcqueen@jhu.edu.

    Click here for more information. 

  • Grants Calendar: Interdisciplinary Research

    As part of our efforts to monitor the funding landscape and facilitate strategic planning, Hanover produces a bimonthly Grants Calendar centered on certain funding interests. Today's calendar reviews upcoming Interdisciplinary Research grant opportunities, covering a range of federal and private funders. Short-term targets with set deadlines are included alongside longer-term opportunities projected to occur across the next year and beyond.

    Please click here to access the calendar:

    Hanover produces two Grants Calendars each month, while also holding a monthly grantsmanship webinar. Please view our upcoming schedule and double check that you are signed up for updates that interest you.

    To learn more about Hanover's work with these programs and the support options available,  please contact Senior Grants Advisor, Clinton Doggett, for a brief conversation.

    HR Digital Grants Portal

    Hanover is excited to share news of the recently-released HR Digital Grants Portal, allowing members to securely access tools and assets that our Grants team has developed and maintains outside of custom work, as a “value-added” part of the Hanover partnership. Under the Calendars section of the Portal, members can access funding calendars from the past year, including opportunities for Minority-Serving Institution, Arts and Humanities, STEM Programming, STEM Research, Health Research, and Early Career Faculty.

  • Grants Calendar: Early Career Research

    Click here for more information on these grants. 

  • Center for Indigenous Innovation and Health Equity - Apply by August 16

    The Office of Minority Health (OMH) at the U.S. Department of Health and Human Services administers grant programs to support projects that implement innovative models to improve minority health and reduce health disparities.

    OMH has released the following funding opportunity announcement for which applications are now being accepted.

    This notice solicits applications for projects to establish a Center for Indigenous Innovation and Health Equity (CIIHE), for which OMH will provide the organizational structure and operational framework.  The CIIHE will support efforts including education, service and policy development, and research related to advancing sustainable solutions to address health disparities and advance health equity in the American Indian and Alaska Native (AI/AN) and Native Hawaiian and Pacific Islander (NHPI) populations. The CIIHE award recipients (awardees) will function as a single initiative, coordinated by OMH, through two cooperative agreements to be awarded through this funding opportunity.

    Click here to access the notice of funding opportunity.

    A technical assistance webinar for potential applicants will be held July 14, 2021 from 3:00-4:00 PM Eastern. Click here to register for the technical assistance webinar.

    Award Amount: $500,000 to $1,000,000
    Estimated Total: $2,000,000  
    Application Due Date: August 16, 2021, 6:00 PM ET 

    Click here for more information on how to apply. 

  • Minority Leaders Development Program - Apply by August 17

    The Office of Minority Health (OMH) at the U.S. Department of Health and Human Services administers grant programs to support projects that implement innovative models to improve minority health and reduce health disparities.

    OMH has released the following funding opportunity announcement for which applications are now being accepted.

    Announcement Number: MP-CPI-21-008
    Award Amount: $500,000 to $750,000
    Estimated Total: $1,500,000
    Application Due Date: August 17, 2021, 6:00 PM ET 

    This notice solicits applications for projects to develop and implement a fellowship program at the U.S. Department of Health and Human Services (HHS) to provide training in health equity issues and leadership to early-career individuals to improve the health of racial and ethnic minorities and other disadvantaged populations. The Minority Leaders Development Program aims to enhance skills and competencies necessary for federal leadership among participants through a curriculum focused on health care policy, leadership skill-building, and cultural competence.

    The program also aims to incorporate fellowship-related work experiences, supplemental learning opportunities, and mentorship. The Minority Leaders Development Program is expected to support efforts to promote diversity, including racial and ethnic minorities, in senior positions within HHS agencies by providing professional development and career pathway opportunities.   

    Learn more about this FOA and how to apply.

    A technical assistance webinar for potential applicants will be held June 29, 2021, from 4:00-5:00 PM ET. Click here to register for the technical assistance webinar.

  • Inter-CFAR Fellowship Program in Implementation Science - Apply by August 20

    On behalf of inter-CFAR Implementation Science Working Group and the Mid-Atlantic CFAR Implementation Science Hub, we are welcoming applications for an NIH-funded training opportunity in implementation science (IS) for early stage investigators (ESIs) engaging in HIV-related research. Since its inaugural class of 2019-2020, the fellowship has engaged 51 fellows in the program. This year’s Implementation Science Fellows will be selected across the CFAR network, HBCUs and U.S. Universities to participate in a mentorship program, including both didactic, online and mentored small group training in IS methodology. The applied mentorship focuses on the development of a grant application which incorporates IS methodology and/or training and is intended to culminate in a two-day grant refinement and networking workshop.

    Fellows are expected to:

    • Complete a series of 12 pre-recorded modules
    • Engage in live Friday discussion sessions throughout the Fellowship to discuss lectures, critical papers in the field, IS methods, and advance their grants
    • Develop a grant incorporating IS research
    • Attend a two-day in-person (Covid-19 dependent) workshop with the mentorship team to present grant progress and receive feedback

     

    which will take place in March 2022, a final decision regarding the exact date of the in-person meeting will be determined in the coming weeks. Please refer to JHU-CFAR (hopkinscfar.org) for details and check back periodically for updates.

    The overarching goal of the fellowship is to support ESIs focused on HIV-related research with training and mentoring opportunities in IS to encourage and capacitate ESIs in the submission of successful IS-focused grants. Specifically, the objectives are:

     

     

    1. Fill an implementation science training gap among emergent HIV-focused investigators
    2. Support ESIs in the development of an implementation science focused grant
    3. Foster cross-institutional networking and mentorship opportunities for ESIs within the field of HIV-implementation science

    Mentoring Team: Stefan Baral (JHU), Chris Hoffmann (JHU), Elvin Geng (Washington University in St. Louis), Vivian Go (UNC), Arianna Means (UW), Denis Nash (CUNY), Sheree Schwartz (JHU), Kenneth Sherr (UW), J.D. Smith (Utah SOM), Patrick Sullivan (Emory), Carolyn Audet (Vanderbilt), Jessica Sales (Emory), Alison Hamilton (UCLA), Larry Hearld (UAB), Paul Cleary (Yale), Sten Vermund (Yale).
     

    Eligibility and logistics: Spots will be reserved exclusively for junior faculty (Assistant Professor, Research Assistant Professor and equivalent positions), post-doctoral fellows, exceptional senior-level PhD candidates. All applicants must be NIH-defined early-stage investigators (ESIs) who have not held an R01 or equivalent award. The Fellowship is targeted at faculty, though exceptional pre- and post-doctoral candidates ready to submit grants will be considered. ESIs who hold or previously held EHE IS grant supplement awards are encouraged to apply, as are candidates from HBCUs.

    Applicants will be asked to submit their NIH formatted biosketch, a one page specific aims document pertaining to the grant that they will be developing, provide basic details of their proposed IS-related grant (e.g. working title, funding mechanism, submission cycle), and a brief summary of their prior experience and planned future directions conducting implementation science research. The specific aims page does not need to be polished and is expected to evolve during the fellowship as IS skills advance. Because grant development is critical to the fellowship, however, we are seeking out applicants who will be submitting a grant that incorporates IS methodology and are committed to moving this forward. Funding will be available for the IS Fellows to attend the 2-day in-person meeting planned for late March or early April 2022.

    Interested applicants should apply online by August 20th, 2021, 11:59 pm EST at:

    http://jhsph.co1.qualtrics.com/jfe/form/SV_3O6NMW7iq4s2wR0

    Outcomes will be announced by August 30th, 2021. The virtual fellowship will begin September 17th, 2021.

    Please direct questions to Sheree Schwartz, PhD: sschwartz@jhu.edu and Lisa Lucas llucas11@jhmi.edu

  • Frameworks to Address Health Disparities through Collaborative Policy Efforts Grants - Apply by August 23

    Announcement Number: MP-CPI-21-003
    Opportunity Title: Framework to Address Health Disparities through Collaborative Policy Efforts: Coordinating Center
    Award Amount: Up to $500,000
    Estimated Total: $500,000
    Application Due Date: August 23, 2021, 6:00 PM ET 

    The Coordinating Center (MP-CPI-21-003), combined with the Office of Minority Health demonstration projects (MP-CPI-21-004), constitute the “Framework to Address Health Disparities through Collaborative Policy Efforts” initiative. The goal of the initiative is to demonstrate the effectiveness of a methodological framework, structured process, and tool in supporting the assessment and identification of policies that may create or perpetuate health disparities by contributing to structural racism, as well as the modification, development, and implementation of policies to improve health outcomes.

    The Coordinating Center will oversee and coordinate complementary and collaborative efforts among the participating sites (OMH-funded and self-funded) through leadership and management toward the goals and objectives of the initiative.

    This notice solicits applications to establish and operate a Coordinating Center that will:

    (1) Lead the development of a methodological framework, process, and tool for the assessment of policies that may create or perpetuate health disparities by contributing to structural racism, in collaboration with MP-CPI-21-004 “Framework to Address Health Disparities through Collaborative Policy Efforts: Demonstration Projects” recipients.
    (2) Provide technical assistance to MP-CPI-21-004 recipients and self-funded participant organizations on utilizing the framework, process, and tool.
    (3) Lead the evaluation of the implementation of the methodological framework, process, and tool.

    Click on the following link to access the notice of funding opportunity.

    A technical assistance webinar for potential applicants will be held July 20, 2021 at 1:00 PM Eastern. Click here to register for the technical assistance webinar.


    Announcement Number: MP-CPI-21-004
    Opportunity Title: Framework to Address Health Disparities through Collaborative Policy Efforts: Demonstration Projects
    Award Amount: Up to $375,000
    Estimated Total: $1,500,000
    Application Due Date: August 23, 2021, 6:00 PM ET 

    The demonstration projects, combined with the Coordinating Center (MP-CPI-21-003), constitute the “Framework to Address Health Disparities through Collaborative Policy Efforts” initiative. The goal of the initiative is to demonstrate the effectiveness of a methodological framework, structured process, and tool in supporting the assessment and identification of policies that may create or perpetuate health disparities by contributing to structural racism. The initiative also focuses on the modification, development, and implementation of policies to improve health outcomes.

    This notice solicits applications for demonstration projects that will:

    (1) Participate in the development of the methodological framework, process, and tool.
    (2) Utilize the methodological framework, process, and tool to assess and identify policies that may create or perpetuate health disparities by contributing to structural racism.
    (3) Modify existing or develop new policies.
    (4) Implement those policies to improve health outcomes.
    (5) Participate in evaluation activities through the Coordinating Center.

    Click the following link to access the notice of funding opportunity.

    A technical assistance webinar for potential applicants will be held July 21, 2021 at 1:00 PM Eastern. Click here to register for the technical assistance webinar.

  • Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited Settings - Apply by August 26

    Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. One such strategic priority is decreasing the disproportionate burden of poor health outcomes faced by patients who receive healthcare in resource limited settings, specifically to address health inequities relating to treatment of infectious diseases.

    Global Bridges Healthcare Alliance, based at Mayo Clinic, is dedicated to supporting global communities of practice to advance evidence-based patient care. Since 2014, Global Bridges has worked collaboratively with Pfizer GMG to support medical education and quality improvement programs in multiple clinical areas, including tobacco dependence treatment, oncology, amyloidosis, and anti-microbial stewardship.

    Geographic Scope: Global

    Clinical Area: Anti-infectives

    Application Due Date: August 26, 2021

    Specific Area of Interest: The purpose of this RFP is to solicit programs that have identified a disparity that impacts antimicrobial stewardship in a resource-limited setting and proposes an intervention to address the disparity to improve and measure patient outcomes.

    Click here for more information.

  • Health and Public Safety Workforce Resiliency Technical Assistance Center - Apply by August 30

    The purpose of this program is to provide tailored training and technical assistance (TA) to Health Resources and Services Administration’s (HRSA’s) health workforce resiliency grant recipients to establish, enhance and expand the capacity and infrastructure to rapidly deploy evidence-informed or evidence-based innovative strategies that promote mental and behavioral health, prevent suicide, as well as reduce burnout and substance use among providers, health care professionals, health care students, residents, professionals, paraprofessionals, trainees, public safety officers and employers of such individuals, collectively known as the “Health Workforce” for the purpose of this NOFO. These health workforce resiliency grant recipients have a special focus on the Health Workforce in rural and medically underserved communities.

    One award will be made for approximately $6 million over three years to provide tailored training and technical assistance to HRSA's workforce resiliency programs.

    Current Closing Date for Applications: August 30, 2021

    Visit Grants.gov to apply.

  • Promoting Resilience and Mental Health Among Health Professional Workforce - Apply by August 30

    The purpose of this program is to provide support to entities providing health care, health care providers associations, and Federally Qualified Health Centers (FQHCs), taking into consideration the needs of rural and medically underserved communities, to establish, enhance, or expand evidence informed or evidenced-based programs or protocols to promote resilience, mental health, and wellness among their providers, other personnel, and members, collectively known as the “Health Workforce.”

    Approximately 10 awards will be made totaling approximately $29 million over three years to health care organizations to support members of their workforce. This includes establishing, enhancing, or expanding evidence-informed programs or protocols to adopt, promote and implement an organizational culture of wellness that includes resilience and mental health among their employees.

    Current Closing Date for Applications: August 30, 2021

    Visit Grants.gov to apply.

  • Health and Public Safety Workforce Resiliency Training Program - Apply by August 30

    The purpose of this program is to plan, develop, operate or participate in health professions and nursing training activities using evidence-based or evidence-informed strategies, to reduce and address burnout, suicide, mental health conditions and substance use disorders and promote resiliency among health care students, residents, professionals, paraprofessionals, trainees, public safety officers, and employers of such individuals, collectively known as the “Health Workforce,” in rural and underserved communities.

    Approximately 30 awards will be made totaling approximately $68 million over three years for educational institutions and other appropriate state, local, Tribal, public or private nonprofit entities training those early in their health careers. This includes providing evidence-informed planning, development and training in health profession activities in order to reduce burnout, suicide and promote resiliency among the workforce. 

    Current Closing Date for Applications: August 30, 2021

    Visit Grants.gov to apply.

  • Proposals Addressing the Intersections of Racial Equity and Healthcare Equity with the WITH Foundation and American Academy of Developmental Medicine and Dentistry - Apply by August 31

    The WITH Foundation (WITH) and the American Academy of Developmental Medicine and Dentistry (AADMD) are partnering in an effort to support projects that address the intersections of racial equity and healthcare equity for adults with intellectual and developmental disabilities.

    This RFP is intended to support projects for a period of one (1) year. This RFP also seeks to foster the development of new partnerships between community, healthcare, and disability organizations. If the proposed project includes organizations that have an established/existing partnership(s), then the proposed project should include significant and new efforts undertaken by the partnership and/or new partners joining the existing collaborative efforts. Partnerships that are led by or include BIPOC-led organizations are strongly encouraged.

    The geographic areas of focus for this RFP are self-selected by the proposing organization/collaborative partners, but must be within the United States. As a result of this RFP, it is anticipated that up to four (4) grant awards will be made. Each grant award will be up to $50,000.

    This is an invitation for collaborative proposals which focus on projects that address the intersections of racial equity and healthcare equity for adults with intellectual and developmental disabilities. Proposals should use one of the following approaches:

    • Implementation: Support implementation of models, i.e., projects that support community-based PCPs in providing care to BIPOC (Black, Indigenous, People of Color) adults with I/DD
    • Educational resources: Develop additional educational resources for Primary Care Providers who serve BIPOC adults with I/DD
    • Research: Support regional or national research related to the care BIPOC adults with I/DD receive from Primary Care Providers.

    A secondary goal of this RFP is to foster new partnerships or significantly enhance existing partnerships between disability organizations, self-advocates, community organizations, and healthcare providers. Proposals and partnerships that are led by or include BIPOC-led organizations are strongly encouraged.

    Award of Grant: Grants of up to $50,000 (each) for 1-year period will be awarded. Please read the information provided on the pages below before submitting your proposal. Additional information will be posted on the Foundation’s website at withfoundation.org.

    Proposal Deadline: Proposals must be submitted online by August 31, 2021 by 5:00 p.m. PDT

    Click here for more information. 

  • Sol Goldman Pancreatic Cancer Research Funding - Apply by September 3

    The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins is pleased to announce that funding is available for a limited number of novel developmental research programs (pilot projects) in the study of adenocarcinoma of the pancreas. This program funds important new pilot projects with promising translational potential that do not have sufficient data for an independently funded NIH grant. Projects of high priority should focus on new research directions, explore innovative ideas, test unconventional, but potentially important, new hypotheses, or ascertain the feasibility of new research approaches. Applications are due Friday, September 3, 2021 at 5:00 p.m.

    Funding is available for novel developmental research programs (pilot projects). Funds ($50,000 per year with the option of re-applying for a second year of funding) may be requested for the salaries of faculty, postdoctoral fellows or technicians, for equipment, and/or for consumable supplies.

    Eligibility: Applicants must hold an MD or PhD degree or both and must have a current academic appointment at Johns Hopkins University. Individuals with nontenure track positions should provide a letter from a tenure track faculty member describing their position and providing assurances of employment during the grant period.

    Click here for more information on how to apply. 

  • American Heart Association Funding Opportunities - First Deadline by September 9

    The AHA will offer training grants and early career funding programs this fall. Deadlines for programs include:

    • September 9: Institutional Award for Undergraduate Student Training: This award is made to qualified institutions that can offer a meaningful research experience that supports the AHA mission that encourages undergraduate college students from all disciplines to consider research careers.
    • September 14: Predoctoral Fellowship: Enhances the training of promising students in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global health and wellbeing.
    • September 15: Postdoctoral Fellowship: Enhances the training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor.
    • September 21: AHA-CHF Congenital Heart Defect Research Awards: The AHA and The Children’s Heart Foundation (CHF) AHA/CHF Congenital Heart Defect Research Awards will support pre- and postdoctoral fellows who are actively conducting basic, clinical, population or translational research directly related to congenital heart defects.
    • September 30: Enduring Hearts Research Awards in Pediatric Heart Transplantation: The Enduring Hearts Foundation and the AHA have established a Collaborative Sciences Award for research specific to solid organ transplantation longevity. The award fosters innovative, collaborative approaches to research. Projects must include at least one co-PI from a field directly related to pediatric heart transplantation and one co-PI from a field not directly related to clinical pediatric heart transplantation research.
  • NIH Director's Pioneer Award Program - Apply by September 10

    The NIH Director’s Pioneer Award Program supports individual scientists of exceptional creativity who propose highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nation’s research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere. The NIH Director’s Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.

    Eligibility: There are no eligibility restrictions.

    Dates: Proposals are due by September 10, 2021.

    Click here for more information. 

  • NOSI: Navigating Pediatric to Adult Health Care: Lost in Transition

    OMH, in partnership with the OASH Office of Infectious Disease and HIV/AIDS Policy (OIDP), has developed a national prize competition to identify innovative and effective approaches to improve pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) utilization among racial and ethnic minority people who are at increased risk of HIV infections or are people with HIV/AIDS. 

    In June, to commemorate the 40th anniversary of the Morbidity and Mortality Weekly Report’s (MMWR) first reporting of HIV, the U.S. government coordinated events and activities across federal agencies and worked together with non-federal partners to end the HIV epidemic focusing on four key themes – Reflect, Recommit, Reenergize, Reengage. 

    The HIV Challenge initiative aligns with “Reenergize” and “Reengage” themes by creating an opportunity for on-the-ground voices to participate in developing novel, innovative approaches that can be successfully implemented within their local, at-risk communities. 

    Information about the HIV Challenge is available in English and Spanish on the OMH website. Registration is open until September 24, 2021.

    Learn More

  • Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy from Pfizer Global Medical Grants  - Rolling Deadline until October 2021

    Date RFP Issued: February 8, 2021

    Geographic Scope: United States

    Clinical Area: Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Link to full RFP: Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Application Due Date: 2021 application windows - please see RFP for details

    Specific Area of Interest: Projects that will be considered for Pfizer support will include local/community activities that focus on improving the care of patients by:

    • Educating [HCPs] to increase awareness and enable appropriate patient identification by closing knowledge gaps in disease epidemiology, pathophysiology, diagnosis, and emerging treatment paradigms.
    • Addressing barriers to appropriate diagnosis and strategies that reduce burdens for patients and providers along the pathway to appropriate diagnosis
    • Exploring strategies that empower patients to play an active role in understanding TTR amyloidosis and decision making regarding available diagnostic and treatment options
    • Increasing awareness of the changing epidemiology of TTR amyloidosis with a focus on the prevalence of hereditary ATTR and wild-type ATTR subtypes as the science continues to evolve
    • Increasing awareness of at risk and undiagnosed populations with TTR amyloidosis with a focus on improving strategies that facilitate the appropriate diagnosis of patients early in the disease course before overt cardiomyopathy has ensued [e.g. populations with electrical disturbances, valvular disease, orthopedic manifestations, and cardio-oncology diseases (i.e. Light Chain Amyloidosis)]
    • Increasing awareness of bone radiotracer scintigraphy as a non-invasive alternative to invasive endomyocardial biopsy for the appropriate diagnosis of TTR cardiac amyloidosis in select patients
    • Supporting the dissemination of information related to the pharmacologic and non-pharmacologic management of ATTR-CM Addressing geographic and racial healthcare disparities
    • Addressing challenges to appropriate diagnoses and caring for patients during an era of increased telehealth utilization
    • Supporting the development of cardiac amyloid centers that provide leadership, best practices, support and/or training of HCPs within a multidisciplinary team environment in order to improve the quality of care for cardiac amyloidosis patients.
  • NOSI: Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities - Open Deadline

    The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in NOT-HD-21-027 "Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition".

    Research Objectives

    NHLBI encourages research that aligns with the Institute's strategic goals and objectives.

    For this NOSI, NHLBI is interested in stimulating research that focuses on the unique health care transition periods for patients with Heart, Lung, Blood and Sleep (HLBS) diseases and disorders.

    With improved rates of survival in childhood illnesses in the United States and globally, individuals are living longer with one or more chronic conditions. During the health care transition period, there are several barriers to accessing and engaging in age-appropriate care which could lead to an increased risk for long-term physical and psychosocial effects from these chronic conditions and their treatments. Children and adolescents with chronic HLBS diseases and disorders often require complex multidisciplinary care. As such, it is critical to ensure that health care transitions in this context include coordination of these complexities of care that are unique to chronic HLBS conditions.

    To harmonize with our ongoing efforts across the Institute’s pediatric research portfolio, this Notice of Special Interest is designed to solicit research that will address the needs of diverse populations with chronic HLBS conditions. Applications responsive to this Notice are encouraged to propose research that will advance our understanding of promising practices designed to facilitate successful health care transitions as well as address barriers and facilitators to such transitions that may be unique to youth with HLBS diseases and disorders. The ultimate goal is to provide a research framework that will enhance quality of care, promote health literacy, and improve patient and family outcomes during and after health care transitions

  • NOSI: Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities - Open Deadline

    Vaccines are a central component of preventive care for populations of high priority to the NICHD. NICHD's priority populations include infants, children, adolescents, pregnant and lactating women, and persons with physical and intellectual disabilities, particularly those who are also underserved or experience health disparities. Strategies that promote access, acceptance and uptake of CDC-recommended vaccines among these populations have the potential not only to reduce the incidence of vaccine-preventable diseases, but also to promote health and well-being and to improve trust in science and health care. The ongoing COVID-19 pandemic makes this initiative especially timely because many jurisdictions seek to effectively deploy vaccines against COVID-19 as they are approved and become more readily available for children. Furthermore, insights gained from this initiative may inform efforts to ameliorate declines in rates of routine childhood and adolescent vaccine delivery.

    The reasons for lower rates of vaccine uptake are varied, but include concerns about vaccine safety, possible long-term side effects, the potential for interactions with prescribed medications, and pre-existing conditions or disabilities. These concerns can be compounded by lack of vaccine acceptance due to skepticism regarding the accuracy or completeness of available information, low perceived risk of infection or severe illness, low perceived efficacy of available vaccines, beliefs regarding other preventive strategies against vaccine-preventable infections, or high perceived risk of adverse events. Finally, structural and historical factors, including costs and systemic barriers that impede access to care, can all have the common end effect of decreasing rates of vaccine access. Social determinants of health (SDoH), defined as the conditions in the environments where people are born, live, learn, work, play, worship and age, intersect with these structural and historical factors in ways that also influence rates of vaccine access, acceptability and uptake. For many NICHD priority populations, vaccine uptake has added complexity because the person providing consent for vaccination may not be the person receiving the vaccine.

    This NOSI encourages applications that address dimensions of access, acceptance and uptake of CDC-recommended vaccines among infants, children, adolescents, pregnant and lactating women, and persons with disabilities, especially among populations who are underserved or experience health disparities.

    Click here for more information.

  • NOSI: Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health - Open Deadline

    This NOSI calls for research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes. Applications may address healthcare regimen initiation, implementation, and/or persistence by patients. Descriptive and intervention research may address adherence determinants at one or more levels of ecologic influence, including the patient, caregiver/family, provider, healthcare system, and community levels. The objective of this NOSI is to encourage research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes. Applications may address healthcare regimen initiation, implementation, and/or persistence by patients. Descriptive and intervention research may address adherence determinants at one or more levels of ecologic influence, including the patient, caregiver/family, provider, healthcare system, and community levels.

    Click here for more information. 

  • NOSI: Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being - Open Deadline

    The Office of Disease Prevention and participating ICOs are issuing this Notice to highlight our interest in encouraging highly innovative and promising translational research to improve our understanding of how to increase and maintain health-enhancing physical activity using multi-level interventions in a wide range of population groups across the lifespan (e.g., including racial and ethnic minorities, children, older adults, persons with medical/behavioral health conditions, and persons with disabilities). This includes efficacy, effectiveness and dissemination and implementation studies. It also includes support for pilot, exploratory, or developmental work in preparation for full-scale, fully powered efficacy studies, preliminary feasibility studies, as well as expanded feasibility work for a discrete, specified, circumscribed project that is based on well-established theory, existing data and evidence-based interventions.

    Click here for more information. 

  • The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) - Various Deadlines

    The purpose of this Funding Opportunity Announcement (FOA) is to support innovative population-based research that can contribute to identifying and characterizing pathways and mechanisms through which work or occupation influences health outcomes and health status among populations with health and/or health care disparities, and how work functions as a social determinant of health.

    This FOA has various deadlines. Click here for more information. 

  • Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) - Various Deadlines

    The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.

    To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

    • Research Experiences

    for high school students, undergraduate students, and/or science teachers during the summer academic break.

    Application Due Dates: March 17, 2022, March 17, 2023, and March 19, 2024

    All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

    Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

    Click here for more information. 

  • AHRQ Health Services Research Dissertation Program (R36) - Various Deadlines

    Applications for dissertation research grants must be responsive to AHRQ’s mission, which is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work with the U.S. Department of Health and Human Services (HHS) and other partners to make sure that the evidence is understood and used. 

    AHRQ welcomes any area of health services research relevant to AHRQ's priority areas as a dissertation project topic.  AHRQ's priority areas of focus are:

    • Research to improve health care patient safety.
    • Harnessing data and technology to improve health care quality and patient outcomes and to provide a 360-degree view of the patient.
    • Research to increase accessibility and affordability of health care by examining innovative market approaches to care delivery and financing.

    Candidates are encouraged to address health services research issues critical to AHRQ priority populations, including: individuals living in inner city or rural (including frontier) areas; low-income and minority groups; women, children, the elderly; and individuals with special health care needs, including those with disabilities and those who need chronic or end-of-life health care.

    Candidates must conduct dissertation projects which focus on health care delivery in the United States. AHRQ will not accept international health care research projects.

    Application Due Date(s): February 1, May 1, August 1, and November 1 annually, beginning August 1, 2018, by 5:00 PM local time of applicant organization.

    Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

    Click here for more information. 

  • Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain from Pfizer Global Medical Grants - Various Deadlines

    Pfizer and Lilly are collaborating to provide grant support for continuing professional education in the areas of Osteoarthritis/ Osteoarthritis Pain. We are committed to supporting innovative, independent medical education for healthcare professionals. Grants via this collaboration will be funded by Pfizer but reviewed and approved by both companies.

    Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

    Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Through this RFP we encourage organizations to submit grant requests that, if funded, will support education in a specific disease state, therapeutic area, or broader area of educational need. Educational activities should not be focused on products specific to Pfizer and/or Lilly.

    For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

    Date RFP Issued: March 3, 2021

    Geographic Scope: Global

    Clinical Area: Pain - Osteoarthritis

    Link to full RFP: Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain

    Application Due Date: multiple application windows - please see RFP documentation

    Specific Area of Interest: Through this RFP, it is our intent to support virtual and potentially live programs and other innovative digital medical education for HCPs. The focus is on Osteoarthritis and Chronic Pain associated with OA and patient-centered standard of care and management including pain and function, the biopsychosocial aspects of the disease, the complexities and challenges of care, and the future of OA/OA pain management. Programs targeted towards reviewing data at virtual or live osteoarthritis, rheumatology, pain, primary care, or other associated medical conferences, including but not limited to OARSI, EULAR, PAINWeek, AAFP, WCO, and ACR are of particular interest, as well as other meaningful education outside of congresses.

  • Notice of Special Interest (NOSI): NINR Priority Areas for Training and Career Development Awards- Various Deadlines

    The National Institute of Nursing Research (NINR) is committed to training the next generation of nurse scientists at all levels of education and encouraging training in important new areas of nursing research. NINR is issuing this Notice to highlight interest in receiving grant applications focused in the following area(s):

    • Social determinants of health
    • Health disparities and health equity
    • Community and population health
    • Observational and intervention research with practice and policy applications
    • Embodiment of social inequalities
    • Multilevel approaches bridging biology to society

    Click here for more information.  

  • Multiple Ruth L. Kirschstein National Research Service Awards - Various Deadlines

    Individual Postdoctoral Fellowship (Parent F32)

    The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers.  Applications are expected to incorporate exceptional mentorship.

    This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

    Click here for more information. 


    Individual Predoctoral Fellowship (Parent F31)

    The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the candidate’s dissertation research project and is expected to clearly enhance the individual’s potential to develop into a productive, independent research scientist.

    This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

    First available due date August 08, 2021

    Click here for more information.


    Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

    The purpose of this Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce.

    Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individual's potential to develop into a productive, independent research scientist.

    This Funding Opportunity Announcement (FOA) does not allow candidates to propose to lead an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial,  but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

    First available due date August 08, 2021

    Click here for more information.

  • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) - Various Deadlines

    The purpose of the NIH Research Conference Grant (R13) is to support high quality scientific conferences that are relevant to the NIH's mission and to the public health. A conference is defined as a symposium, seminar, workshop, or any other organized and formal meeting, whether conducted face-to-face or via the internet, where individuals assemble (or meet virtually) for the primary purpose to exchange technical information and views or explore or clarify a defined subject, problem, or area of knowledge, whether or not a published report results from such meeting. The NIH recognizes the value to members of the research community and all other interested parties in supporting such forums.

    The NIH recognizes that the value of conferences is enhanced when persons from diverse backgrounds and perspectives are included in all aspects of conference/meeting planning and when attendees are assured of a safe, respectful, and inclusive environment free from discrimination, harassment, and other barriers that might prevent or inhibit one’s participation. NIH encourages conference grant applicants to enhance diversity by increasing the participation of individuals from diverse backgrounds, including those from underrepresented groups, in the planning and implementation, and ultimately, participation in the proposed conference. Per NIH Notice of Interest in Diversity NOT-OD-20-031, underrepresented groups include individuals from nationally (US) underrepresented racial and ethnic groups, individuals with disabilities, individuals from disadvantaged backgrounds, and women. Applications for NIH support of conferences and scientific meetings must include a plan to enhance diversity in all aspects of conference planning and implementation. Diversity plans will be assessed during the scientific and technical merit review of the application. Though the proposed plans will not be scored individually, they will be considered in the overall impact score (see Updated Guidelines on Enhancing Diversity and Creating Safe Environments in Conferences Supported by NIH Grants and Cooperative Agreements, NOT-OD-21-053).

    NIH is also committed to changing the culture of science to end sexual harassment and other forms of harassment, including harassment on the basis of race, color, national origin, sex/gender, disability, and age  in NIH-funded activities. Harassment, in any form, is detrimental and presents obstacles that hinder an individual’s ability to fully participate in science. Only in safe, respectful, and inclusive environments can individuals achieve their fullest potential and support the mission of the NIH. As stated in NOT-OD-15-152, Civil Rights Protections in NIH-Supported Research, Programs, Conferences and Other Activities, consistent with existing federal civil rights laws, it is expected that organizers of NIH-supported conferences and scientific meetings take steps to maintain a safe and respectful environment for all attendees by providing an environment free from all forms of discrimination and harassment, sexual or otherwise. It is expected that organizers of NIH-supported conferences employ strategies that seek to prevent or mitigate the effects of discrimination and harassment, sexual and otherwise. Below are examples of strategies, which are not inclusive of all strategies, that could be employed to support a safe environment (conference organizers should consider additional strategies as appropriate):

    Establishing a conference code of conduct with clearly stated expectations of behavior, systems of reporting, and procedures for addressing inappropriate behavior. The code of conduct and reporting mechanisms should be clear and accessible to all meeting attendees.

    • Providing resources to support individuals who report incidents of harassment, including:
      • personnel trained in advocacy and counseling
      • referrals to legal or health care resources
      • procedures for ensuring the safety of all conference attendees, up to and including removing a perpetrator from the conference
    • Conducting conference climate surveys specifically related to sexual harassment and professional misconduct

    Additionally, all NIH sponsored and/or supported conferences must be held at accessible sites, as outlined by section 504 of the Rehabilitation Act of 1973 and, as applicable, the Americans with Disabilities Act of 1990. Conference registration materials should provide a questionnaire that will allow participants with disabilities to voluntarily identify any special needs, so that conference organizers can make plans to accommodate these needs.

    Support of conferences is contingent on the fiscal and programmatic interests and priorities of the individual NIH Institutes and Centers (ICs). Therefore, a conference grant application is required to contain a permission-to-submit letter from any one of the participating ICs' conference grant contact person (see Contacts List). Applicants are urged to initiate contact well in advance of the chosen application due date and no later than 6 weeks before that date. Please note that agreement to accept an application does not guarantee funding. In general, NIH will not issue a conference grant award unless the Federal award date can precede the conference start date.

    Click here for more information. 

  • Evidence for Action: Investigator-Initiated Research to Build a Culture of Health - Open Deadline

    Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation (RWJF), funds research that expands the evidence needed to build a Culture of Health. A Culture of Health is broadly defined as one in which good health and well-being flourish across geographic, demographic, and social sectors; public and private decision-making is guided by the goal of fostering equitable communities; and everyone has the opportunity to make choices that lead to healthy lifestyles. RWJF’s Culture of Health Action Framework, which was developed to catalyze a national movement toward improved health, well-being, and equity, guides E4A’s program strategy.

    Eligibility and Selection Criteria

    Preference will be given to applicants that are either institutes of higher education, public entities, or nonprofit organizations that are tax exempt under Section 501(c)(3) of the Internal Revenue Code and are not private foundations or Type III supporting organizations. Other types of nonprofit and for-profit organizations are also eligible to apply. The Foundation may require additional documentation. Applicant organizations must be based in the United States or its territories. Submissions from teams that include both U.S. and international members are eligible, but the lead applicant must be based in the United States.

    Key Dates

    We hosted an applicant webinar on April 12, 2019.

    During the webinar, we:

    • Reviewed our updated Call for Proposals and the different phases in the application process
    • Discussed what it means to be an E4A grantee
    • Hosted a live Q&A period with participants.

    A recording is available here.

    Since applications are accepted on a rolling basis, there is no deadline for submission. Generally, applicants can expect to be notified within 6-9 weeks of their LOI submission. Applicants invited to the full proposal stage will have 2 months to submit their proposal once they receive notification. Full proposal funding decisions will generally be made within 6-9 weeks of the submission deadline.

    Total Awards

    There is not an explicit range for allowable budget requests. You should request the amount of funding you will need to complete your proposed research project – including both direct and indirect costs for the entire duration of your study. Typical grant durations may be up to 36 months, with some exceptions when durations of up to 48 months are justified. Visit the Grantee section of our website for a sense of the number and size of grants funded by E4A at http://www.evidenceforaction.org/grantees.

    For more information on how to apply, click here.

  • Pioneering Ideas: Exploring the Future to Build a Culture of Health - Open Deadline

    Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.

    We want to hear from scientists, anthropologists, artists, urban planners, community leaders—anyone, anywhere who has a new or unconventional idea that could alter the trajectory of health, and improve health equity and well-being for generations to come. The changes we seek require diverse perspectives and cannot be accomplished by any one person, organization or sector. 

    Eligibility and Selection Criteria

    Preference will be given to applicants that are tax exempt under Section 501(c)(3) of the Internal Revenue Code and are not private foundations or Type III supporting organizations. Applicant organizations must be based in the United States or its territories. Submissions from teams that include both U.S. and international members are eligible, but the lead applicant must be based in the United States.

    Applications will be evaluated based on, but not limited to, the following criteria:

    • Strength of health equity focus: How will this project increase opportunities for everyone to live the healthiest life possible, no matter who they are, where they live, or how much money they make? 
    • Strength of insight: How will this project help us anticipate, adapt to, and influence the future in 5 to 15 years?
    • Strength of idea: Is this project pioneering in one or more of these ways?
      • Offers a new take or perspective on a long-running, perplexing problem
      • Challenges assumptions or cultural practices
      • Takes an existing idea and gives it a new spin—or a novel application
      • Applies ideas from other fields
      • Explores how an emerging trend will shape the future
      • Describe in which other way you see your project as pioneering

    Key Dates

    Proposals will be accepted throughout the year on a rolling admission.  

    Total Awards

    The average Pioneer grant in 2019 was $315,031. However, there is not an explicit range for budget requests. Grant periods are flexible, though generally range from 1 to 3 years.

    Click here to apply.

  • Notices of Special Interest (NOSIs) on COVID-19 - Various Deadlines

    Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

    Notice Number:
     NOT-OD-20-097

    Expiration Date: April 1, 2021

    Purpose:
    This NOSI highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. This NOSI encourages urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts,including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.

    View NOT-OD-20-097

    Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

    Notice Number:
     NOT-DA-20-047

    Expiration Date: March 31, 2021

    Purpose:
    The National Institute on Drug Abuse (NIDA) is issuing this NOSI to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

    View NOT-DA-20-047


    Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus

    Notice Number:
     NOT-MH-20-047

    Expiration Date: April 16, 2021

    Purpose:
    The National Institute of Mental Health (NIMH) is issuing this NOSI to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. NIMH is especially interested in research to provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest to NIMH.

    View NOT-MH-20-047


    Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

    Notice Number:
     NOT-AG-20-022

    Expiration Date: May 1, 2021

    Purpose:
    The National Institute on Aging (NIA) is issuing this NOSI to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). The mission of NIA is to support and conduct genetic, biological, clinical, behavioral, social, and economic research on aging. This NOSI supports mission critical areas of research for NIA as they relate to the COVID-19 pandemic.

    View NOT-AG-20-022

  • 2020 Reimagine Education Awards - Open Deadline

    QS Quacquarelli Symonds – compilers of the QS World University Rankings – and The Wharton School have now opened the 2020 Reimagine Education Awards, which are offering $50,000 and global visibility to an outstanding approach to teaching or learning.

    The Awards were contested by 1518 university faculty, cross-departmental teams, and edtech companies in 2019, and have received over 5000 submissions since their 2014 inauguration – making them currently the world’s largest educational awards program.

    Previous winners include Harvard University, Massachusetts Institute of Technology, Imperial College London, and the London School of Economics.

    There are also 14 Category Award Winners – with categories including Virtual Reality, Artificial Intelligence, Hybrid Learning, Presence Learning, and Best Educational App – and awards available for outstanding submissions by region and by discipline.

    All applications can be made free of charge, and can be submitted by visiting www.Reimagine-Education.com/application. There is no restriction on the number of unique applications that can be made by an individual institution or department.

  • Johns Hopkins University Center for AIDS Research (CFAR) Small Grants Program - Various Deadlines

    The purpose of the small grants program is to offer financial assistance for HIV/AIDS research outside of our usual award mechanisms, on an ongoing basis.

    Funds are to be used to:

    • Collect or analyze data/specimens to inform a research application (new or under revision for re-submission)
    • Provide incentives to enhance/expand enrollment
    • Provide salary support for staff or a student to expand or add an aim to an existing protocol.
    • Extend currently funded research (i.e. expand analysis, enlarge scope)
    • Overcome an obstacle to currently funded research or application (i.e. Advertising, Grant writer)
    • Test the feasibility of an idea (acceptability of intervention, recruitment method, etc.)
    • Preliminary Projects (Focus groups, qualitative interviews, survey)
    • Manuscript preparation
    • Other needs? Just ask.

    Application Submission:

    Interested applicants are encouraged to contact before beginning the application process, in order to discuss the fit of your request with the CFAR goals for the Small Grants Program.

    Complete an application package HERE

    The application package should include the following:

    A completed “Small Grants” request form

    A copy of the applicant’s NIH biosketch

    Eligibility:

    Any CFAR member who meets the NIH definition of “Early Stage Investigator Senior faculty will be considered on an exceptional ad hoc basis

    Any Hopkins faculty member or post-doc conducting HIV/AIDS research

    This program provides reimbursement or direct purchases of up to $5,000 per approved request.

    Approvals:

    Projects that require institutional approvals (e.g. IRB, IACUC) must have copies of those approvals on file with the Developmental Core before funds will be released.

    Deadlines:

    Rolling. Submissions will be circulated for review by the CFAR Developmental Core and other invited reviewers and a decision made within 4 weeks of application.

  • France-Merrick Foundation - Open Deadline

    The France-Merrick Foundation concentrates its grant-making within the State of Maryland and primarily within the greater Baltimore area. Applicants must be a non-profit organization holding 501(c)(3) status under the Internal Revenue Code.

    The Foundation favors one-time, project-oriented requests which have defined beginnings and endings, as opposed to annual giving or ongoing operational support.  Applicants must have the financial stability to sustain the project for which funding is being sought.   In addition, applicants are expected to demonstrate adequate administrative capacity, financial stability and program effectiveness, including the ability to describe evaluation criteria, methods and expected outcomes in their requests.

    The Foundation does not provide funding for:

    • Individuals
    • Special events or advertising space in programs
    • Deficit financing/debt reduction
    • Political activities 
    • General operating/annual giving

    If the request involves new construction or renovation of an existing building, special attention will be given to the sustainable building practices and energy conservation measures being incorporated into the project.

    Click here to apply. 

  • Amgen Foundation Grants - Open Deadline

    The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators, and invest in strengthening communities where Amgen staff members live and work. The Amgen Foundation carefully considers each grant application it receives, seeking out diverse organizations whose philosophies, objectives and approaches align with the Foundation goals and mission.

    The Foundation awards grants to local, regional, and international nonprofit organizations that are replicable, scalable and designed to have a lasting and meaningful effect in our communities. Grants should reflect Amgen's dedication to impacting lives in inspiring and innovative ways. Amgen Foundation grants range from $10,000 to multi-million dollar commitments.

    The Amgen Foundation has established grant-making partnerships with qualified intermediary partners to manage donations to organizations chartered outside of the United States.

    Click here to apply. 

  • Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 Clinical Trail Optional) - Various Deadlines

    The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make health care safer, of higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used.

    This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.

    Transition to the R33 phase is not guaranteed for all grants awarded under this FOA. Continuation from the R21 phase to the R33 phase will be determined by AHRQ staff based on progress achieved in the R21 phase and factors such as program priorities and availability of funds.  

    Application Due Date: Standard dates apply.   

    All applications are due by 5:00 PM local time of the applicant organization

    Applicants are encouraged to apply early to allow adequate time to for them to make, by the due date, corrections to any errors found in the application during the submission process.

    Click here for more information. 

  • Anderson-Rogers Foundation - Open Deadline

    The Anderson-Rogers Foundation makes grants to 501(c)(3) organizations that address a variety of social and environmental needs. The Foundation is particularly interested in funding programs in the following areas:

    • Reproductive and abortion rights
    • Access to contraception and sex education, particularly programs aimed at reducing teen pregnancy rates
    • Environmental education and activism, including programs to preserve and restore habitat and protect endangered animals
    • Promotion of environmentally sound agricultural practices and food systems
    • Promotion of humanist values and separation of church and state

    Click here to register. 

  • Semnani Family Foundation - Rolling Deadline

    The mission of the Semnani Family Foundation is to find creative and effective ways of serving the needs of marginal and vulnerable communities around the world, particularly those whose survival and security is at grave risk or immediate danger due to forces and factors beyond their control. Whether it is helping communities recover from disease, famine, earthquake or war, or promoting research, educational and civic initiatives, we focus our giving where we can make the most difference.

    Deadline: Rolling

    Grant Amount: $27,000,000

    For additional information visit http://semnanifamilyfoundation.org/

  • Cigna Foundation World of Difference Grants - Rolling Deadline

    The Cigna Foundation is deeply committed to providing opportunities for individuals everywhere to achieve the best possible health. We pursue that goal through our World of Difference Grants. Our overall World of Difference focus is Health Equity, helping people overcome barriers to their health and well-being related to factors such as ethnicity, race, gender, age, geography, or economics. World of Difference Grants emphasize partnership: sharing the knowledge and expertise of Cigna's professionals with dedicated non-profit partners. We believe that together, we can make "A World of Difference" in both individual and community health.

    Deadline: Rolling

    Grant Amount: US $50,000 - US $150,000

    Click here for more information. 

  • Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31) - Various Deadlines

    This funding opportunity is to enable promising predoctoral fellows to obtain interdisciplinary training from outstanding faculty sponsors in bioinformatics and scientific research relevant to the mission of NIDDK's Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD).  This training will require mentorship in both bioinformatics and metabolic disease disciplines.  In order to advance bioinformatics science and encourage its application to these diseases and disorders, NIDDK invites applications from individuals with novel individual development plans (IDP).  The fellowship training plan should focus on interdisciplinary approaches and mentorship among data or computer science and medicine in topics related to diabetes, endocrinology and metabolic diseases.

    This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

    Application Due Date: Standard dates apply

    All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

    Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

    Click here for more information. 

  • Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32) - Various Deadlines

    This Funding Opportunity Announcement (FOA) is to enable promising postdoctoral fellows to obtain interdisciplinary training from outstanding faculty sponsors in bioinformatics and scientific research relevant to the mission of NIDDK's Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD).  This training will require mentorship in both bioinformatics and metabolic disease disciplines.  In order to advance bioinformatics science and encourage its application to these diseases and disorders, NIDDK invites applications from individuals with novel individual development plans (IDP).  The fellowship training plan should focus on interdisciplinary approaches and mentorship among data or computer science and medicine in topics related to diabetes, endocrinology and metabolic diseases.

    This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

    Application Due Date: Standard dates apply

    All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

    Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

    Click here for more information. 

  • Funding News Updates

    nih sample grant applications, summary statements, and more...

    Sample Grant Applications, Summary Statements, and More

    If you are new to writing grant applications, sometimes seeing how someone else has presented their idea can help as you are developing your own application. With the gracious permission of successful investigators, the National Institute of Allergy and Infectious Diseases (NIAID) makes available examples of funded R01, R03, R15, R21, SBIR/STTR, K, and F applications, summary statements, sharing plans, leadership plans, and more. Continue reading 

    New Salary Cap for NIH Grants : $192,300

    Effective, January 6, 2019, the salary limitation for Executive Level II is $192, 300. For awards issued in those years that were restricted to the prior Executive Level II, including competing awards already issued in FY2019, if adequate funds are available in active awards, and if the salary cap increase is consistent with the institutional base salary, grantees may rebudget funds to accommodate the current Executive Level II salary level.  However, no additional funds will be provided to these grant awards.

    Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements (NOT-OD-19-098)

    Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements (NOT-OD-19-098)

    Reminder for NIH Grants submitted on or after January 25, 2019: Inclusion Across the Lifespan

    The policy applies to all NIH conducted or supported research involving human subjects, including research that is otherwise “exempt” under the new Common Rule.

    Policy: Individuals of all ages, including children and older adults, must be included in all human subjects research, unless there are scientific or ethical reasons not to include them.

    Applications for research involving human subjects must address the age-appropriate inclusion or exclusion of individuals in the proposed research project. Applications must include a description of plans for including individuals in the proposed research project including a rationale for selecting the specific age range justified in the context of the scientific question proposed. If individuals will be excluded from the research based on age, the proposal must include an acceptable justification for the exclusion.

    The policy applies to all NIH conducted or supported research involving human subjects, including research that is otherwise “exempt” under the new Common Rule

    Policy: Individuals of all ages, including children and older adults, must be included in all human subjects research, unless there are scientific or ethical reasons not to include them.

    Applications for research involving human subjects must address the age-appropriate inclusion or exclusion of individuals in the proposed research project. Applications must include a description of plans for including individuals in the proposed research project including a rationale for selecting the specific age range justified in the context of the scientific question proposed. If individuals will be excluded from the research based on age, the proposal must include an acceptable justification for the exclusion.

    The Federal Common Rule lays out requirements for IRBs

    The Federal Common Rule lays out requirements for IRBs. Effective 1/21/19, the REVISED Common Rule takes effect.

    One part of the changes deals with what constitutes exempt research (not requiring IRB review or requiring just a limited review)

    Changes are set forth in the link below:  

    https://www.medstarhealth.org/mhri/focusblog/2018/01/07/revised-common-rule-changes-mean-research/

    Questions? Please contact Deb Brodlie, Director, Sponsored Projects and Business Development

    Revised NIH Grants Policy Statement for Fiscal Year 2019

    NIH has released a revised Grants Policy Statement that applies to all NIH grants and cooperative agreements with budget periods beginning on or after October 1, 2018. This revised version does not introduce new policies, but it does incorporate all policy changes or updates made throughout the previous year and includes significant enhancements to improve the user interface, navigation, and search. Continue reading →

    New Application Requirements for Institutional Training Grants:

    Letter of Institutional Commitment to Harassment and Discrimination Protections

    NIH takes the issue of sexual harassment and discrimination very seriously. As such, beginning with applications submitted for due dates on or after January 25, 2019, institutional training grant applications (T15, T32, T34, T35, T36, T37, T90/R90, TL1, TL4) must include a letter that describes the institutional commitment to ensuring that proper policies, procedures, and oversight are in place to prevent discriminatory harassment and other discriminatory practices. Continue reading →


    LEARN MORE

    Legislative Mandates for Fiscal Year 2019

    NIH issued a notice detailing statutory provisions that limit or condition the use of funds on NIH grant, cooperative agreement, and contract awards for FY 2019. These provisions include:

    Salary Limitation Gun Control

    For additional details, see NOT-OD-19-030.

    Anti-Lobbying Acknowledgment of Federal Funding Restriction on Abortions, with exceptions Ban on Funding Human Embryo Research Limitation on Use of Funds for Promotion of Legalization of Controlled Substances Restriction on disclosure of political affiliation for Federal scientific advisory committee candidates Dissemination of False or Misleading Information Restriction of Pornography on Computer Networks Restriction on Distribution of Sterile Needles